Dissolved and financials
CVR: 36558008
Previous names: BIOVERO IVS
DKK 0
Gross profit
Net result: DKK -710
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 16 April 2019
CVR · view overview
No headcount reported
Director role ended: Kim Bo Weifenbach Ankjær Nielsen
CVR · 03/01/2019
View the full event history
Nordporin IVS was a Danish company of the type Iværksætterselskab based in Fredericia, founded in 2015. The company has been dissolved on 16 April 2019. The company was registered under the industry Uoplyst. The company was previously named BIOVERO IVS. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK -710 compared with DKK -985 the year before. Equity in the 2018 report amounted to DKK 349.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/04/2017 – 31/03/2018 | 0 | -710 | 349 | 349 | - | |
| 201701/04/2016 – 31/03/2017 | 0 | -985 | 6 t. | 6 t. | - | |
| 201625/02/2015 – 31/03/2016 | 0 | -4 t. | 4 t. | 4 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationNo. Nordporin IVS is registered in the Danish CVR register with the status Dissolved and ceased on 16 April 2019.
The CVR number of Nordporin IVS is 36558008.
In 2018, Nordporin IVS reported a gross profit of DKK 0.
Nordporin IVS was founded on 25 February 2015.
Nordporin IVS was registered under the industry Uoplyst (industry code 999999).
Nordporin IVS was located at Nyvej 4, 7000 Fredericia.
Nordporin IVS was dissolved on April 16, 2019.
As of January 3, 2019, Kim Bo Weifenbach Ankjær Nielsen has stepped down as director of Nordporin IVS.
As of October 1, 2018, Claus Weber has stepped down as director of Nordporin IVS.
Nordporin IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -710.
As of November 11, 2017, Kim Bo Weifenbach Ankjær Nielsen is registered as director of Nordporin IVS.
Nordporin IVS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -985.
As of October 5, 2016, Andreas Mørck Nielsen has stepped down as director of Nordporin IVS.
As of September 27, 2016, Mads Arreborg Olsen has stepped down as director of Nordporin IVS.
As of September 27, 2016, Kim Bo Weifenbach Ankjær Nielsen has stepped down as director of Nordporin IVS.
On September 27, 2016, the company changed its name from BIOVERO IVS to Nordporin IVS.
Nordporin IVS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK -3,586.
As of February 25, 2015, Claus Weber is registered as director of Nordporin IVS.
As of February 25, 2015, Mads Arreborg Olsen is registered as director of Nordporin IVS.
As of February 25, 2015, Andreas Mørck Nielsen is registered as director of Nordporin IVS.
As of February 25, 2015, Kim Bo Weifenbach Ankjær Nielsen is registered as director of Nordporin IVS.
Nordporin IVS was founded on February 25, 2015.
